Literature DB >> 33865761

Cardiac Imaging in Carcinoid Heart Disease.

Tomasz Baron1, Johannes Bergsten2, Anders Albåge3, Lennart Lundin2, Jens Sörensen4, Kjell Öberg5, Frank A Flachskampf6.   

Abstract

Carcinoid disease is caused by neuroendocrine tumors, most often located in the gut, and leads in approximately 20% of cases to specific, severe heart disease, most prominently affecting right-sided valves. If cardiac disease occurs, it determines the patient's prognosis more than local growth of the tumor. Surgical treatment of carcinoid-induced valve disease has been found to improve survival in observational studies. Cardiac imaging is crucial for both diagnosis and management of carcinoid heart disease; in the past, imaging was accomplished largely by echocardiography, but more recently, imaging for carcinoid heart disease has increasingly become multimodal and warrants awareness of the particular diagnostic challenges of this disease. This paper reviews the pathophysiology and manifestations of carcinoid heart disease in light of the different imaging modalities.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  carcinoid disease; multimodality imaging; pulmonary regurgitation; tricuspid regurgitation; valvular heart disease

Mesh:

Year:  2021        PMID: 33865761     DOI: 10.1016/j.jcmg.2020.12.030

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  3 in total

1.  Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.

Authors:  Camilla Schalin-Jäntti; Niina Matikainen; Iiro Kostiainen; Noora Karppinen; Piia Simonen; Milla Rosengård-Bärlund; Riikka Lindén; Maija Tarkkanen; Daniel Gordin; Janne Rapola
Journal:  Endocrine       Date:  2022-05-10       Impact factor: 3.925

2.  Multimodality imaging in the diagnostic approach to a patient with carcinoid heart disease involving four heart valves.

Authors:  Shirin Habibi Khorasani; Mozhgan Parsaee; Niloufar Samiei; Mahshid Hesami; Feridoun Noohi; Saeid Hosseini; Golnaz Houshmand
Journal:  Clin Case Rep       Date:  2022-07-25

3.  European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease.

Authors:  Simona Grozinsky-Glasberg; Joseph Davar; Johannes Hofland; Rebecca Dobson; Vikas Prasad; Andreas Pascher; Timm Denecke; Margot E T Tesselaar; Francesco Panzuto; Anders Albåge; Heidi M Connolly; Jean-Francois Obadia; Rachel Riechelmann; Christos Toumpanakis
Journal:  J Neuroendocrinol       Date:  2022-05-25       Impact factor: 3.870

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.